Home › Funds › Citadel Advisors › CCCC

Citadel Advisors position in CCCC

C4 THERAPEUTICS INC · Health Care

Latest position (Q2 2026)24.60K sh
Reported value held$114.88K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 47.44K $2.12M New
Q4 2021 180.46K $5.81M Add
Q1 2022 142.93K $3.47M Reduce
Q2 2022 39.15K $295.00K Reduce
Q3 2022 145.39K $1.27M Add
Q4 2022 392.60K $2.32M Add
Q1 2023 559.05K $1.76M Add
Q2 2023 703.08K $1.93M Add
Q3 2023 418.24K $777.93K Reduce
Q4 2023 353.11K $2.00M Reduce
Q1 2024 542.62K $4.43M Add
Q2 2024 531.56K $2.46M Reduce
Q3 2024 137.90K $786.01K Reduce
Q4 2024 157.42K $566.70K Add
Q3 2025 535.85K $1.19M New
Q4 2025 498.61K $952.34K Reduce
Q1 2026 2.59M $6.81M Add
Q2 2026 24.60K $114.88K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding CCCC

All CCCC fund holders →